Philips announces new imaging and workflow enhancements for KODEX-EPD cardiac imaging and mapping system to treat heart rhythm disorders
26 août 2020 04h00 HE
|
Royal Philips
August 26, 2020 New release combines faster, higher resolution imaging for Medtronic cryoablation proceduresKODEX-EPD system now installed at 40 sites worldwide with over 1500 patients treated ...
Philips and B. Braun receive FDA clearance for breakthrough Onvision needle tip tracking technology for regional anesthesia
25 août 2020 09h00 HE
|
Royal Philips
August 25, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and B. Braun, a global market leader [1] in regional anesthesia and pain...
Philips introduces OmniWire, the world’s first solid core pressure guide wire for coronary artery interventional procedures
17 août 2020 09h00 HE
|
Royal Philips
August 17, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of OmniWire, the world’s first solid core...
New data reconfirms long-term safety profile of the Philips Stellarex low-dose Drug-Coated Balloon
26 juin 2020 04h00 HE
|
Royal Philips
June 26, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the four-year results from the ILLUMENATE European Randomized...
Philips and Leeds Teaching Hospitals NHS Trust to set new standards for specialist integrated cardiac care
25 juin 2020 04h00 HE
|
Royal Philips
June 25, 2020 Seven-year agreement puts patients at heart of service design to support increased excellence across specialist care, research and local care provision Amsterdam, the...
Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images
11 févr. 2020 09h00 HE
|
Royal Philips
February 11, 2020 Randomized controlled trial with up to 3,000 participants at 75 sites to compare outcomes between physiological guidance by iFR data co-registered on the angiogram...
Four-year data from ILLUMENATE Pivotal trial reaffirms safety profile of Philips Stellarex low-dose Drug-Coated Balloon
28 janv. 2020 10h00 HE
|
Royal Philips
January 28, 2020 Mortality rates similar to standard of care through four years with excellent rate of follow-up compliancePhilips Stellarex is the only low-dose Drug-Coated Balloon (DCB) to...
One millionth procedure carried out on Philips Azurion advanced image-guided therapy platform
27 nov. 2019 11h00 HE
|
Royal Philips
November 27, 2019 Industry-leading platform combines clinical excellence and workflow innovation, helping clinicians and hospitals to deliver outstanding patient care ...
Philips announces WE-TRUST multicenter clinical trial to assess impact of ‘Direct to Angio Suite’ workflow on stroke patient outcomes
27 nov. 2019 10h00 HE
|
Royal Philips
November 27, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major clinical trial...
Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients
15 oct. 2019 04h00 HE
|
Royal Philips
October 15, 2019 Stellarex’s unique coating enables a low therapeutic drug dose and has demonstrated a significant treatment effect and high safety profile Amsterdam, the...